✦ LIBER ✦

Vasopeptidase inhibitor reduces inhospital costs for patients with congestive heart failure: Results from the IMPRESS trial

✍ Scribed by Eric L. Eisenstein; Charlotte L. Nelson; Teresa A. Simon; Allison L. Smitten; Pablo Lapuerta; Daniel B. Mark

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CV3: VASOPEPTIDASE INHIBITOR REDUCES IN-

✍ EL Eisenstein; CL Nelson; TA Simon; AL Smitten; P Lapuerta; DB Mark 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Comparison of vasopeptidase inhibitor, o

✍ Jean L Rouleau; Marc A Pfeffer; Duncan J Stewart; Debra Isaac; Francois Sestier; 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 102 KB

A health perception score predicts cardi

✍ Edward P. Havranek; Pablo Lapuerta; Teresa A. Simon; Gilbert L'Italien; Alan J. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Valsartan Reduces the Incidence of Atria

✍ A.P. Maggioni; R. Latini; P.E. Carson 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Valsartan reduces the incidence of atria

✍ Aldo P. Maggioni; Roberto Latini; Peter E. Carson; Steven N. Singh; Simona Barle 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 306 KB

Management of patients with congestive h

✍ Clyde W. Yancy; Mitchell Saltzberg; Robert L. Berkowitz; Darlene P. Horton; Marc 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 49 KB